LOAN AND SECURITY AGREEMENTLoan and Security Agreement • April 2nd, 2007 • Igi Inc • Biological products, (no disgnostic substances) • New Jersey
This Loan and Security Agreement is entered into as of November ___, 2006 by and between IGI, Inc., a Delaware corporation with an address of 105 Lincoln Avenue, Buena, New Jersey 08310 ("Borrower") and Pharmachem Laboratories, Inc. with an address of 266 Harrison Avenue, Kearny, New Jersey 07032 (together with its successors and assigns, "Lender").
AGREEMENTCollaboration Agreement • April 2nd, 2007 • Igi Inc • Biological products, (no disgnostic substances)
This Agreement is made this 11th day of October 2006 by and between DermWoRX Incorporated, a Delaware corporation whose offices are located at 934 S. Southlake Drive, Hollywood, Florida 33019 (hereinafter, "DERMWORX") and IGI, Inc., a Delaware corporation whose offices are located at 105 Lincoln Avenue, Buena, New Jersey 08310 ("IGI").
EMPLOYMENT AGREEMENTEmployment Agreement • April 2nd, 2007 • Igi Inc • Biological products, (no disgnostic substances) • Delaware
EMPLOYMENT AGREEMENT (this "Agreement"), effective as of January 1, 2007 (the "Effective Date") by and between IGI, Inc., having an address at 105 Lincoln Avenue, Buena, New Jersey 08310 ("Company") and Rajiv Mathur have an address at 35 Milestone Drive, Ringoes, New Jersey 08551("Executive"). Company and Executive are referred to hereinafter as the "Parties".
NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY APPLICABLE STATE SECURITIES LAW AND NEITHER MAY BE SOLD OR OTHERWISE...Common Stock Purchase Warrant • April 2nd, 2007 • Igi Inc • Biological products, (no disgnostic substances) • New Jersey
THIS CERTIFIES THAT, FOR VALUE RECEIVED, LANDMARK FINANCIAL CORPORATION or its registered assigns ("Holder") is entitled to purchase, on the terms and conditions hereinafter set forth, at any time or from time to time from the date hereof until 5:00 p.m., Eastern Time, on the second anniversary of the Original Issue Date set forth above, or if such date is not a day on which the Company (as hereinafter defined) is open for business, then the next succeeding day on which the Company is open for business (such date is the "Expiration Date"), but not thereafter, to purchase up to one hundred and fifty thousand (150,000) shares of the Common Stock, $.01 par value (the "Common Stock"), of IGI, Inc., a Delaware corporation (the "Company"), at $1.00 per share (the "Exercise Price"), such number of shares and Exercise Price being subject to adjustment upon the occurrence of the contingencies set forth in this Warrant. Each share of Common Stock as to which this Warrant is exercisable is a "War
IGI, INC. SUBSCRIPTION AGREEMENT (the "Agreement") Date: February 5, 2007 To: IGI, Inc. Buena, NJ 08310 Attention: Carlene Lloyd Vice President of FinanceSubscription Agreement • April 2nd, 2007 • Igi Inc • Biological products, (no disgnostic substances) • New Jersey
Reference is made to (a) IGI, Inc.'s 10-K for the Year ended December 31, 2005 and its filings under the Securities Exchange Act of 1934, as amended since the date of such Form 10-K (the "Exchange Act Filings").
